2004
DOI: 10.1016/j.biopsych.2004.08.010
|View full text |Cite
|
Sign up to set email alerts
|

High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
121
1
1

Year Published

2006
2006
2021
2021

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 117 publications
(130 citation statements)
references
References 40 publications
7
121
1
1
Order By: Relevance
“…This, along with the observation that β2-nAchR knockout mice are more prone to learned helplessness [13], emphasizes that there is a strong relationship between nicotinic receptor modulation and mood control. Nicotine, administered acutely and chronically, shows an antidepressant-like effect on the behavior of FSL rats (bred for cholinergic hypersensitivity) in the forced swim test [79], implicating the involvement of central nicotinic receptors in the depressive characteristics of the FSL rats.…”
Section: Discussionmentioning
confidence: 95%
“…This, along with the observation that β2-nAchR knockout mice are more prone to learned helplessness [13], emphasizes that there is a strong relationship between nicotinic receptor modulation and mood control. Nicotine, administered acutely and chronically, shows an antidepressant-like effect on the behavior of FSL rats (bred for cholinergic hypersensitivity) in the forced swim test [79], implicating the involvement of central nicotinic receptors in the depressive characteristics of the FSL rats.…”
Section: Discussionmentioning
confidence: 95%
“…19 A relationships has also been found between smoke and depression, 20 and both agonists (such as nicotine) and antagonists are effective in animal models of depression. 21,22 Several nicotinic agonists are under development as analgesics, 23 and ABT-089, a compound in phase II for AD, is also under evaluation for Attention-Deficit Hyperactivity Disorder (ADHD) in adults. 24 Varenicline, an orally active α4β2 nicotinic partial agonist, is now in clinical trials for smoking cessation.…”
Section: Introductionmentioning
confidence: 99%
“…Consistent with a role for nAChRs in regulation of anxiety-like behavior, mice lacking either the α4 subunit or the α7 subunit show less anxiety-like behaviors [122,142]. With respect to depression-like behavior, β2 KO mice do not respond to classical and atypical antidepressants, emphasizing the relationship between the cholinergic and the monoaminergic systems in mood disorders [143][144][145]. Interestingly, these mice are also less immobile in the forced swim and tail suspension tests at baseline, suggesting that β2* nAChRs may normally have a role in regulating mood.…”
Section: Genetically-manipulated Mouse Models: Beyond Addictionmentioning
confidence: 87%